Innate Pharma SA(IPHA)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Innate Pharma SA (IPHA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. IPHA is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 10 institutional filers currently hold this stock. Top institutional holders of IPHA by reported 13-F value include Lion Point Capital, MORGAN STANLEY, SmartHarvest Portfolios, based on the most recent SEC filings. IPHA trades on the Nasdaq exchange and files with the SEC under CIK 1598599. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IPHA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Innate Pharma SA directly from SEC EDGAR.

IPHA key financials by period

Innate Pharma SA reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202520-F$9.0M
FY 202420-F$20.1M
FY 202320-F$61.6M
FY 202220-F$57.7M
FY 202120-F$24.7M
FY 202020-F$69.8M

Institutions holding IPHA

Institutional investors reporting a position in Innate Pharma SA on SEC Form 13F.
InstitutionSharesValueReported
Lion Point Capital81,151$149.3K2026-06-30
MORGAN STANLEY43,524$80.1K2026-06-30
SmartHarvest Portfolios23,750$43.7K2026-06-30
XTX Topco Ltd15,130$27.8K2026-06-30
CITADEL ADVISORS12,441$22.9K2026-06-30
JANE STREET GROUP10,310$19.0K2026-06-30
RHUMBLINE ADVISERS4,719$8.7K2026-06-30
UBS Group AG1,363$2.5K2026-06-30
Farther Finance Advisors21$38.002026-06-30
GAMMA Investing9$17.002026-06-30
IPHA

Innate Pharma SA

IPHA
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 10 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Financial metrics will appear once SEC EDGAR data is ingested for this company.

Top Institutional Holders

as of Q2 2026
$354.0K total
Loading ratio trend…